HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francisco Vega Selected Research

Interferons

1/2023Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francisco Vega Research Topics

Disease

48Neoplasms (Cancer)
02/2024 - 04/2000
29Lymphoma (Lymphomas)
03/2024 - 04/2006
17B-Cell Lymphoma (Lymphoma, B Cell)
11/2023 - 01/2011
13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 10/2009
10Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2022 - 05/2002
9Hodgkin Disease (Hodgkin's Disease)
12/2023 - 11/2011
8Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2024 - 06/2011
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 04/2002
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 08/2011
5Hypersensitivity (Allergy)
11/2022 - 01/2012
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 06/2007
4T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 09/2003
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 10/2009
4Genetic Translocation (Chromosomal Translocation)
09/2020 - 04/2002
3Inflammation (Inflammations)
01/2023 - 01/2019
3Urticaria (Hives)
04/2019 - 10/2010
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2018 - 03/2016
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2018 - 05/2002
2Hyperplasia
03/2024 - 01/2021
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 01/2019
2Breast Neoplasms (Breast Cancer)
01/2022 - 09/2008
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019 - 02/2002
2Glioma (Gliomas)
05/2013 - 11/2011
2Multiple Myeloma
08/2011 - 06/2005
1Sialadenitis
10/2023
1Cytopenia
01/2023
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2022
1Thrombocytopenia (Thrombopenia)
06/2022
1Cytokine Release Syndrome
01/2022

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
06/2022 - 04/2000
9Rituximab (Mabthera)FDA Link
11/2023 - 12/2013
7RNA (Ribonucleic Acid)IBA
01/2023 - 06/2005
7Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2008
5Chimeric Antigen ReceptorsIBA
02/2024 - 01/2022
5Doxorubicin (Adriamycin)FDA LinkGeneric
12/2023 - 12/2013
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 12/2013
4CytokinesIBA
11/2023 - 01/2019
4AntigensIBA
11/2023 - 02/2002
4Anaplastic Lymphoma KinaseIBA
06/2022 - 07/2006
4Adenosine Triphosphate (ATP)IBA
01/2018 - 10/2009
3ChromatinIBA
03/2024 - 11/2018
3Brentuximab VedotinIBA
12/2023 - 01/2018
3Vincristine (Oncovin)FDA LinkGeneric
11/2023 - 12/2013
3ibrutinibIBA
01/2023 - 01/2022
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2023 - 02/2002
3AntibodiesIBA
02/2012 - 04/2006
2Prednisone (Sone)FDA LinkGeneric
11/2023 - 12/2013
2Lenalidomide (CC 5013)FDA Link
01/2023 - 01/2022
2Immunoglobulin E (IgE)IBA
11/2022 - 10/2010
2Immunoglobulin G (IgG)IBA
11/2022 - 04/2020
2Phosphotransferases (Kinase)IBA
06/2022 - 01/2011
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022 - 12/2013
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 12/2013
2Cyclin D1IBA
01/2022 - 01/2018
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 12/2013
2Uracil-DNA GlycosidaseIBA
03/2021 - 09/2020
2venetoclaxIBA
01/2021 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2019
2Alemtuzumab (Campath)FDA Link
01/2019 - 05/2002
2Oncogene Proteins (Oncogene Protein)IBA
11/2018 - 01/2013
2Transcription Factors (Transcription Factor)IBA
11/2018 - 11/2011
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2018 - 01/2011
2EnzymesIBA
11/2018 - 10/2002
2TNF Receptor-Associated Factor 6 (TRAF6)IBA
11/2018 - 06/2013
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2015 - 06/2011
2MicroRNAs (MicroRNA)IBA
08/2013 - 01/2013
2Messenger RNA (mRNA)IBA
02/2012 - 06/2011
2Pyridinolcarbamate (P23)IBA
07/2006 - 05/2002
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2002 - 04/2002
1Enhancer of Zeste Homolog 2 ProteinIBA
03/2024
1Biological FactorsIBA
01/2024
1Vinblastine (Vinblastine Sulfate)FDA Link
12/2023
1Dacarbazine (DIC)FDA LinkGeneric
12/2023
1Circulating Tumor DNAIBA
11/2023
1Iohexol (Omnipaque)FDA Link
10/2023
1iobitridolIBA
10/2023
1iopromide (Ultravist)FDA Link
10/2023
1AntioxidantsIBA
01/2023
1InterferonsIBA
01/2023
1Thrombopoietin (c-mpl Ligand)IBA
01/2023
1Neutralizing AntibodiesIBA
01/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2022
1AlarminsIBA
11/2022
1Complement System Proteins (Complement)IBA
11/2022
1Interleukin-13IBA
11/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2022
1Transaminases (Aminotransferases)IBA
06/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Insulin-Like PeptidesIBA
01/2022
1omega-Chloroacetophenone (Mace)IBA
01/2022
1tocilizumab (atlizumab)FDA Link
01/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2022
1CD19-specific chimeric antigen receptorIBA
01/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2022
1Capsules (Microcapsules)IBA
12/2021

Therapy/Procedure

19Therapeutics
12/2023 - 05/2002
14Drug Therapy (Chemotherapy)
01/2023 - 02/2002
4Breast Implants (Breast Implant)
11/2023 - 01/2018
1Stem Cell Transplantation
01/2023
1Preoperative Exercise
10/2022